Can-Fite BioPharma (CANF) EPS (Basic) (QoQ) (2014 - 2023)
Can-Fite BioPharma (CANF) EPS (Basic) (QoQ) (2014 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Can-Fite BioPharma | 2.82 Mn | -8.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -855.55% |
| Sep 30, 2023 | 32.78% |
| Jun 30, 2023 | -6.03% |
| Mar 31, 2023 | 93.63% |
| Dec 31, 2022 | -7.64% |
| Sep 30, 2022 | -24.30% |
| Jun 30, 2022 | 14.95% |
| Mar 31, 2022 | 75.40% |
| Dec 31, 2021 | 53.97% |
| Sep 30, 2021 | -288.89% |
| Jun 30, 2021 | 459.45% |
| Mar 31, 2021 | 68.01% |
| Dec 31, 2020 | 80.84% |
| Sep 30, 2020 | -215.25% |
| Jun 30, 2020 | 354.89% |
| Mar 31, 2020 | 90.95% |
| Dec 31, 2019 | -601,735.76% |
| Sep 30, 2019 | 100.04% |
| Jun 30, 2019 | -290,507.97% |
| Mar 31, 2019 | 100.21% |